Background The advances of research on extracellular vesicles (EVs) are of particular
interest to the clinicians as well as the researchers who are studying coagulation disorder in …

Longtime considered as inert cellular debris, microvesicles (MVs) have gained tremendous
attention in the past decade. MVs are 100–1000 nm vesicles released into the extracellular …

Essentials• PSGL‐1+ microvesicles (MVs) may be important in venous thromboembolism
(VTE).• We measured plasma levels and parental origin of PSGL‐1+ MVs in patients with …

Microparticles (MPs) are shed membrane vesicles released from a variety of cell types in
response to cellular activation or apoptosis. They are elevated in a wide variety of disease …

Objective: The aim of this study was to determine whether the activity of tissue factor (TF)
and tissue factor pathway inhibitor (TFPI) in the plasma of women with preeclampsia (PE) …

I hereby certify that the work embodied in this thesis contains published papers of which I am
a joint first author. I have included as part of the thesis a written statement from each …

One of the greatest challenges in the production of platelets ex vivo is implementing a
system that does not require expensive media and time-consuming laboratory practices that …

Wound healing is a highly organized process that occurs after tissue injury, resulting in the
formation of a scar. Over the past few decades, several studies have been conducted to …

Venous thromboembolism (VTE) is a common disease with an incidence of 1–2 per 1000
individuals. VTE is a collective term for deep vein thrombosis and pulmonary embolism …

1. Inoue T, Node K. Vascular failure: A new clinical entity for vascular disease. J Hypertens
2006; 24: 2121–2130. 2. Kohashi K, Nakagomi A, Morisawa T, Endoh I, Kawaguchi N …